Latest filing published 24 Jan 2007 for Enzo Biochem INC.
No signal scores available.
This profile gathers the share dealings of Irwin Gerson across 2 companies, led by Andrx Corp /DE/ and Enzo Biochem Inc. We count 5 filings; the first trade dates from 19 January 2006 and the latest from 23 January 2007.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 24 January 2007 with a share grant in Enzo Biochem Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations